A comparative study of Limited Cutaneous Systemic Sclerosis versus diffuse cutaneous systemic sclerosis

Introduction: Systemic Sclerosis (SSc) is a multi-system connective tissue disorder of unknown aetiology characterised by thickening and stiffening of skin. SSc is clinically classified as limited cutaneous systemic sclerosis (LCSSc) and diffuse cutaneous systemic sclerosis (DCSSc). Objective: To compare the cutaneous and systemic features of LCSSc with those of DCSSc. Materials and Methods: A cross-sectional, descriptive study was conducted over a period of eight years in a tertiary care centre. All the patients of SSc were classified as LCSSc and DCSSc. Cutaneous features, systemic features and laboratory parameters were evaluated and compared between these two groups. Results: 54 cases of SSc were recruited for the study; of which 18 belonged to LCSSc and 36 to DCSSc. Female to male ratio was 5:1 in LCSSc and 11:1 in DCSSc. Mean age were 26.10±10.68 years and 34.72±15.95 years in LCSSc and DCSSc respectively. Statistically significant difference was observed in parameters like mean age, duration of Raynaud’s phenomenon, digital pitted scars, microstomia, diffuse hyperpigmentation, salt and pepper pigmentation, dyspnea on exertion, arthralgia, raised ESR and abnormality in spirometry. Conclusion: The duration of Raynaud’s phenomenon and digital pitted scars were significantly higher in LCSSc than DCSSc whereas microstomia, diffuse hyperpigmentation, salt and pepper pigmentation, dyspnea on exertion, arthragia, raised ESR and restrictive ventilatory defect were significantly higher in DCSSc than LCSSc. Pulmonary, renal and cardiac involvement were relatively less in our study population compared to other studies. Keywords: Limited cutaneous systemic sclerosis, diffuse cutaneous systemic sclerosis, Raynaud’s phenomenon, icrostomia, digital pitted scars, salt and pepper pigmentation.

[1]  Noha Khalil,et al.  Disease characteristics of systemic sclerosis among Egyptian patients , 2015 .

[2]  S. Kaveri,et al.  Clinical and Autoimmune Profile of Scleroderma Patients from Western India , 2014, International journal of rheumatology.

[3]  S. Ghosh,et al.  Mucocutaneous and Demographic Features of Systemic Sclerosis: A Profile of 46 Patients From Eastern India , 2012, Indian journal of dermatology.

[4]  C. L. Teh,et al.  Systemic sclerosis in Sarawak: a profile of patients treated in the Sarawak General Hospital , 2009, Rheumatology International.

[5]  A. Wells,et al.  Scleroderma lung disease: evolving understanding in light of newer studies , 2008, Current opinion in rheumatology.

[6]  T. Medsger,et al.  Clinical subsets, skin thickness progression rate, and serum antibody levels in systemic sclerosis patients with anti-topoisomerase I antibody. , 2007, Arthritis and rheumatism.

[7]  V. Marwaha,et al.  Prevalence of renal involvement in Indian patients with systemic sclerosis. , 2007, Indian journal of medical sciences.

[8]  Vinod K. Sharma,et al.  Profile of systemic sclerosis in a tertiary care center in North India. , 2006, Indian journal of dermatology, venereology and leprology.

[9]  S. Ndongo,et al.  [Systemic scleroderma: 92 cases in Dakar]. , 2003, Dakar medical.

[10]  T. Al-Sayed,et al.  Clinical features of systemic sclerosis. , 2001, Saudi medical journal.

[11]  J. Raynauld,et al.  Updating the American College of Rheumatology preliminary classification criteria for systemic sclerosis: addition of severe nailfold capillaroscopy abnormalities markedly increases the sensitivity for limited scleroderma. , 2001, Arthritis and rheumatism.

[12]  R. Porkodi,et al.  Progressive systemic sclerosis in south India. , 1991, The Journal of the Association of Physicians of India.

[13]  Nicholas Bellamy,et al.  Connective Tissue Diseases , 1985 .

[14]  M. Sackner,et al.  The heart in scleroderma. , 1966, The American journal of cardiology.